SciELO - Scientific Electronic Library Online

 
vol.58 número3Estudio bibliométrico sobre el impacto de los medicamentos biosimilaresGuía de actuación para el farmacéutico comunitario en enfermedad inflamatoria intestinal índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

  • Em processo de indexaçãoCitado por Google
  • Não possue artigos similaresSimilares em SciELO
  • Em processo de indexaçãoSimilares em Google

Compartilhar


Ars Pharmaceutica (Internet)

versão On-line ISSN 2340-9894

Resumo

PATHAN, Inayat Bashir; MENE, Harshal  e  BAIRAGI, Shripad. Quality by design (QbD) approach to formulate in situ gelling system for nose to brain delivery of Fluoxetine hydrochloride: Ex-vivo and In-vivo study. Ars Pharm [online]. 2017, vol.58, n.3, pp.107-114.  Epub 12-Dez-2022. ISSN 2340-9894.  https://dx.doi.org/10.30827/ars.v58i3.6528.

Objective:

The purpose of the present study is to develop an ion sensitive in situ nasal gel of Fluoxetine hydrochloride for brain delivery. A 32 factorial design was used to investigate effect of independent variable on dependent variables.

Methods:

Formulations were evaluated for gelation study, viscosity, gel strength, mucoadhesion strength, drug content, ex-vivo drug permeation, in vivo pharmacodynamic and stability study.

Results:

The results revealed that as the concentration of gellan gum and HPMC were increased, there was increase in viscosity and mucoadhesive strength and decrease in percent release. The optimized formulation F4 showed highest drug release 94.24 %. In locomotor activity and forced swim test study, the in situ gel treated rats showed significant responses as compared to control group. Histopathological examinations showed no evidence of nasal mucosal damage. The in situ nasal gel was stable after 3 months.

Conclusion:

It was concluded that, the in situ nasal formulations of Fluoxetine hydrochloride which enhanced nasal absorption and patient compliance for the treatment of depression.

Palavras-chave : Nasal; Fluoxetine hydrochloride; Pharmacodynamic.

        · resumo em Espanhol     · texto em Inglês     · Inglês ( pdf )